SGX (SGD): Raffles Medical (BSL)
Last Price
0.825
Today's Change
-0.01 (1.197%)
Day's Change
0.825 - 0.835
Trading Volume
2,323,200
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
2024-12-02
DBS Buys Back Nearly S$15m of Its Shares; AGT Partners Becomes Oiltek’s Substantial Shareholder
2024-11-25
ABR Holdings Managing Director Continues to Grow Interest
2024-11-11
SIA Engineering Resumes Buybacks After Reporting H1 FY2025 Results
2024-11-04
Zheneng Jinjiang Environment Continues Buyback Pace
2024-10-07
Buybacks Continue at Moderate Pace; Far East Orchard Chair Acquires Shares
2024-10-01
Retail Investors Capitalise on Recent Market Upswing
2024-09-30
Raffles Medical Executive Chairman Expands Interest; First REIT Independent Director Cashes in
2024-08-12
Cohen & Steers Ups Digital Core REIT Interest, Beng Kuang Marine CEO Also Adds to Interest
2024-07-30
Raffles Medical- 1H24 Numbers Below Expectations
2024-07-08
UOL Chairman Wee Ee Lim Builds Interest
2024-06-24
LMS Compliance Directors Augment Interests
2024-06-14
Recent Net Retail Flow in Singapore Stocks
2024-06-12
Broader Universe of SG Index Stocks With a Decarbonisation Lens
2024-06-10
Real Estate Directors Building Up Their Company Stakes
2024-06-05
Raffles Medical - No Near-Term Catalysts, New ESG Data
2024-06-03
The Tang Group Ventures Into the S-Reit Sector
2024-05-27
AEM, UMS, NetLink and Baker Tech Directors Acquire Stock
2024-05-20
Wilmar and Raffles Medical Chairmen Continue Buying Spree
2024-05-13
Wilmar, Raffles Medical Chairs Continue Adding to Stakes
2024-04-15
Sam Goi Continues to Boost His Stakes in PSC and GSH
2024-04-01
Union Steel Co-founder Ang Yew Chye Ups Stake
2024-03-18
Raffles Medical Executive Chair Continues Acquisitions, CDL Leads Buyback Consideration
2024-03-11
Director Filings & Buybacks Continue Stronger Pace
2024-03-04
Director Filings and Buyback Momentum Return
2024-02-28
Raffles Medical Group Ltd – Lacklustre Near-term
2024-02-27
Raffles Medical - Waiting for China Business to Breakeven
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
Kioxia's Shares Surge in Debut, Valuing Japan Chipmaker at US$5.8b
2
Singapore's ChemOne Delays Pengerang Complex's Start to 2028
3
Allianz Pulls Out of US$1.7 Bil Bid to Buy Stake in Singapore Insurer
4
Grab Stock’s Big Quarter Has Some Analysts Seeing Further Gains
5
Baltic Exchange Shipping Updates: Dec 13, 2024
#
Stock
Score
STI ETF
1000
HG Metal
HG Metal Manufacturing Ltd
336
DBS
DBS Group Holdings Ltd
195
OCBC Bank
Oversea-Chinese Banking Corporation Ltd
169
Mapletree Log Tr
Mapletree Logistics Trust
154
6
UOB
United Overseas Bank Ltd
153
7
SIA
Singapore Airlines Ltd
150
8
CapLand IntCom T
148
9
Mapletree Ind Tr
Mapletree Industrial Trust
147
10
Singtel
Singapore Telecommunications Ltd
142
Stock Name
Last
Change
Volume
Envictus
0.345
0.00
91,449,357
Golden Agri-Res
0.255
-0.005
69,699,500
ESR-LOGOS REIT
0.25
55,616,500
Clearbridge
0.004
+0.001
48,742,200
1.91
-0.01
47,770,300
HPH Trust USD
0.168
+0.018
44,415,600
Genting Sing
0.75
40,261,900
HSI 18800MBePW250127
0.064
+0.002
29,665,500
ThaiBev
0.55
29,620,500
3.12
+0.02
29,490,500
Tencent 5xLongSG251216
2.21
+0.30
2,000
NVDA 3xLongSG261006
5.46
+0.275
2,700
MSFT 3xShortSG261204US$
+0.225
100
Xiaomi 5xLongSG251113
1.39
+0.187
33,000
AMZN 3xLongSG261006
6.90
+0.181
800
APPLE 3xLongSG261006
5.33
+0.168
600
Tencent HK SDR 10to1
7.44
+0.15
93,400
Lyxor MSIndia US$
32.85
16
ALPHAB3xShortSG261204US$
3.91
+0.131
300
XT MSCHINA S$
20.79
+0.13
1,527
SPDR S&P500 US$
584.36
-8.46
2,821
SPDR DJIA US$
424.35
-3.65
26
GLD SG$
326.70
-2.30
1,349
TESLA 3xLongSG261006
19.35
-1.469
4,300
GLD US$
240.98
-1.12
8,451
Nasdaq 7xLongSG260226
12.46
-1.109
5,400
JMH USD
40.23
-0.96
438,000
35.84
-0.70
3,552,700
Nasdaq 7xLongUB250922
11.65
-0.60
42.82
-0.58
4,996,738
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....